Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Topical Administration of BOS-475 in Healthy Subjects and Patients With Psoriasis

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 23, 2019

Primary Completion Date

January 28, 2020

Study Completion Date

January 28, 2020

Conditions

Psoriasis

Interventions

DRUG

BOS-475

topical cream

DRUG

Vehicle

topical cream

Trial Locations (3)

CMAX Clinical Research, Adelaide

Sinclair Dermatology, East Melbourne

Linear, Nedlands